| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-11 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |